KRYS vs TT · P/E 46, rev $290.5M vs P/E 36, rev $21.32B
Krystal Biotech Inc (KRYS) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the KRYS and TT stock pages for the full models.
Not investment advice.